3 years ago


C. Nelson-Piercy, L.S. Exton, C.H. Smith, R.T. Woolf, E. Pottinger, A.D. Burden
生物疗法可以有效治疗银屑病,并且通常在育龄期女性中使用。监管部门表示,由于没有充分的研究评估在受孕或妊娠期使用生物制剂的安全性,因此建议在此期间禁用。但事实上,这实施起来很有挑战,因为临床上治疗银屑病需要持续进行。为评估受孕和/或者妊娠期使用生物疗法的安全性,该研究的作者(来自英国)对有关女性在受孕和/或妊娠期使用生物疗法治疗银屑病的相关研究进行了系统综述。作者确定了四项研究,共涉及 1,300 名在孕前 3 个月或孕期前 3 个月使用 TNFi 生物制剂的女性。这些研究表明具有不同炎症(不仅仅是银屑病)的女性在使用 TNFi 后容易出现药物特定的损害,而且其中三项研究表明先天畸形风险增加,一项研究表明早产风险增加。但是,风险很低且不确定是否因 TNFi 所致。作者得出结论,生物制剂对妊娠结局(特别是女性银屑病患者)的潜在影响尚缺乏充分研究,无法准确量化。有关在其他病例中的生物制剂使用数据十分有限。通常建议有生育能力的女性使用常规避孕,但在备孕的情况下,应视具体情况讨论继续或停止生物治疗的风险及好处。大规模研究是必需的,并且应考虑其他可能影响妊娠的因素,比如疾病活动性、其他疗法及母体人口统计特征。

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1111/bjd.16206

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.